Low Energy Cost PCR System Offers Five Channel Multiplexing Capability
|
By LabMedica International staff writers Posted on 21 Nov 2011 |
|
Image: The PikoReal Real-Time PCR System (Photo courtesy of Thermo Fisher Scientific).
A new, energy-saving PCR system has entered the United States biotech market and will be available in Europe in the second half of 2012.
The Thermo Fisher Scientific Inc. (Milford, MA, USA) PikoReal Real-Time PCR System is available as either a 24-well or a 96-well instrument that utilizes proprietary UTW Piko PCR Plates. These plates are a quarter the size and half the thickness of standard PCR plates but still maintain industry standards for well volumes and well spacing, thus having compatibility with standard multichannel pipettes (both eight- and 16-channel) and liquid handling robots. The Piko PCR plates enable shorter incubation times and improved data uniformity by improving thermal transfer between block and sample.
The built-in optical system of the PikoReal contains five channels, precalibrated for the most common dyes, so users can perform multiplexing with four dyes while dedicating the fifth channel to SYBR Green (an asymmetrical cyanine dye used as a nucleic acid stain in molecular biology) experiments. Data is collected from all wells simultaneously with a low noise and high sensitivity CCD camera (520 nm to 740 nm). The scanning time for all four channels is less than 10 seconds, supporting the development of fast qPCR (quantitative real-time polymerase chain reaction) protocols for multiplexing.
Five long-lasting LEDs are used as the instruments' light source. These lamps emit constant and stable light over a broad spectrum (475 nm to 640 nm) and require no user maintenance. Separate light sources of different excitation wavelengths reduce crosstalk and focus high light energy levels.
The instruments are controlled by PikoReal software, which enables absolute and relative quantification, melting curve analysis, and genotyping.
The PikoReal PCR system is now being marketed in the US and it will become available in Canada, Brazil, and Western Europe beginning the second half of 2012.
Related Links:
Thermo Fisher Scientific Inc.
The Thermo Fisher Scientific Inc. (Milford, MA, USA) PikoReal Real-Time PCR System is available as either a 24-well or a 96-well instrument that utilizes proprietary UTW Piko PCR Plates. These plates are a quarter the size and half the thickness of standard PCR plates but still maintain industry standards for well volumes and well spacing, thus having compatibility with standard multichannel pipettes (both eight- and 16-channel) and liquid handling robots. The Piko PCR plates enable shorter incubation times and improved data uniformity by improving thermal transfer between block and sample.
The built-in optical system of the PikoReal contains five channels, precalibrated for the most common dyes, so users can perform multiplexing with four dyes while dedicating the fifth channel to SYBR Green (an asymmetrical cyanine dye used as a nucleic acid stain in molecular biology) experiments. Data is collected from all wells simultaneously with a low noise and high sensitivity CCD camera (520 nm to 740 nm). The scanning time for all four channels is less than 10 seconds, supporting the development of fast qPCR (quantitative real-time polymerase chain reaction) protocols for multiplexing.
Five long-lasting LEDs are used as the instruments' light source. These lamps emit constant and stable light over a broad spectrum (475 nm to 640 nm) and require no user maintenance. Separate light sources of different excitation wavelengths reduce crosstalk and focus high light energy levels.
The instruments are controlled by PikoReal software, which enables absolute and relative quantification, melting curve analysis, and genotyping.
The PikoReal PCR system is now being marketed in the US and it will become available in Canada, Brazil, and Western Europe beginning the second half of 2012.
Related Links:
Thermo Fisher Scientific Inc.
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Automated Urinalysis Solution
UN-9000
Latest BioResearch News
- Study Reveals Diagnostic and Therapeutic Target in Rare Pancreatic Tumors
- Researchers Identify Survival Pathway Undermining Targeted Cancer Drugs
- Large-Scale Study Maps DNA Damage Signatures Across Multiple Cancers
- Study Identifies Distinct Immune Signatures to Early Depression and Psychosis
- Genetic Mutation Behind Aggressive Adult Leukemia Offers Treatment Clues
- Disease Gene Discovery Advances Diagnosis of Rare Movement Disorders
- Genetic Discovery Could Improve Diagnosis of Drug-Resistant Epilepsy
- Genetic Discovery May Improve Diagnosis of Rare Dementia Subtype
- Mass Spectrometry Technique Detects Protein and Sugar Changes in Neurodegeneration
- Barcoded DNA Sheds Light on Hidden Complexities in Breast Cancer Detection
- CRISPR-Based Platform Pinpoints Drivers of Acute Myeloid Leukemia in Patient Cells
- Protective Brain Protein Emerges as Biomarker Target in Alzheimer’s Disease
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
Channels
Clinical Chemistry
view channel
New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs
Steroid hormone measurement is a core application of clinical mass spectrometry, which is widely regarded as a diagnostic gold standard. Access to these high-specificity methods has often been constrained... Read more
Study Shows Dual Biomarkers Improve Accuracy of Alzheimer’s Detection
Alzheimer’s disease develops slowly, and biological changes can appear in blood many years before symptoms. While plasma assays for phosphorylated tau offer earlier detection, discerning whether these... Read more
Molecular Diagnostics
view channel
Whole Genome Sequencing in Routine Care Expands Rare Disease Detection
Rare diseases often involve prolonged diagnostic journeys that delay clinical decision-making and complicate family planning. As phenotypes become more heterogeneous, sequencing-based methods are increasingly... Read more
New AI Tool Improves Detection of Genetic Causes in Rare Disorders
Families affected by rare diseases often endure years of inconclusive testing and fragmented referrals before a definitive diagnosis. Despite broad access to genomic sequencing, many patients remain undiagnosed,... Read more
Hematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Immunology
view channel
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas
Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer
Bladder cancer remains a prevalent malignancy with variable responses to immune checkpoint inhibitors. Clinicians often observe elevated C-reactive protein and interleukin-6 in affected patients, yet the... Read more
Microbiology
view channel
New Bacterial Target Identified for Early Detection of Noma
Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. Without treatment, it... Read more
Genomic Analysis Links Emerging Streptococcal Strains to Specific Infections
Streptococcus dysgalactiae subspecies equisimilis (SDSE) infections are increasing worldwide and include variants that may lead to severe disease. Researchers now report that whole-genome sequencing of... Read more
Pathology
view channel
AI Tool Predicts Patient-Specific Chemotherapy Benefit in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer is typically guided by recurrence risk and population-level averages rather than patient-specific benefit. However, existing clinicopathologic... Read more
AI-Based Pathology Model Guides Chemotherapy Decisions in Breast Cancer
Selecting adjuvant chemotherapy for early-stage breast cancer remains a difficult decision because only a subset benefits and many undergo toxicity without gain. Genomic assays can help but are costly,... Read more
Technology
view channel
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species.... Read more
Industry
view channel
Takara Bio USA and Hamilton Partner Partner to Automate NGS Library Preparation
Takara Bio USA, Inc. (San Jose, CA, USA), a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company (Reno, NV, USA) announced a development and co-marketing agreement to deliver integrated, automated... Read more
